PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics

Zeng, Y., Arisa, O., Peer, C. J., Fojo, A., & Figg, W. D. (2024). PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics. Seminars in Oncology, 51(1–2), 19–24. https://doi.org/10.1053/j.seminoncol.2023.09.005
Authors:
Yi Zeng
Oluwatobi Arisa
Cody J Peer
Antonio Fojo
William D Figg
Affiliated Authors:
Antonio Fojo
Columbia Affiliation:
Subjects:
Antineoplastic Agents (MeSH)
Neoplasms (MeSH)
Ovarian Neoplasms (MeSH)
Author Keywords:
cancer
dna repair
oncology
parp inhibitors
pharmacogenetics
pharmacokinetics
pharmacology
elink
Publication Type:
Article
Unique ID:
10.1053/j.seminoncol.2023.09.005
PMID:
37880048
DOI:
10.1053/j.seminoncol.2023.09.005
Journal:
Seminars in Oncology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: